{"url":"https://etfiq.com/holdings/acrs/","section":"holdings","title":"ACRS ETFs: 28 Funds That Hold Aclaris Therapeutics | ETFIQ","description":"28 thematic and core ETFs hold Aclaris Therapeutics (ACRS). XPH holds the most, at 0.85% of the fund on Nov 3, 2026. Weights and dates for every holder.","as_of":"Nov 5, 2026","structured_data":[{"@type":"Dataset","@id":"https://etfiq.com/holdings/acrs#data","name":"ETFs holding Aclaris Therapeutics","description":"Every US listed ETF that holds Aclaris Therapeutics, with each fund\u2019s published weight and filing date.","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"variableMeasured":["Share of fund","Holdings filing date"],"license":"https://etfiq.com/license/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/alternatives.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/core.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/crypto.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/funds.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/thematic.json"}]},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which ETFs hold Aclaris Therapeutics?","acceptedAnswer":{"@type":"Answer","text":"28 thematic and core ETFs hold Aclaris Therapeutics, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are XPH at 0.85% of the fund on Nov 3, 2026, DWAS at 0.55% of the fund on Nov 3, 2026 and SBIO at 0.44% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Holdings","item":"https://etfiq.com/holdings/"},{"@type":"ListItem","position":3,"name":"ACLARIS THERAPEUTICS","item":"https://etfiq.com/holdings/acrs/"}]},{"@type":"WebPage","name":"ACRS ETFs: 28 Funds That Hold Aclaris Therapeutics","description":"28 thematic and core ETFs hold Aclaris Therapeutics (ACRS). XPH holds the most, at 0.85% of the fund on Nov 3, 2026. Weights and dates for every holder.","url":"https://etfiq.com/holdings/acrs/","dateModified":"2026-11-04","isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".lede",".faq"]},"publisher":{"@id":"https://etfiq.com/#org"}}],"characters":4036,"truncated":false,"content":"ETFIQ / Holdings / ACLARIS THERAPEUTICS \n \n ETFs that hold Aclaris Therapeutics\n 28 thematic and core ETFs hold Aclaris Therapeutics , by holdings dated Jun 30, 2026 to Nov 3, 2026 . XPH holds the most, at 0.85% of the fund on Nov 3, 2026 . The next largest are DWAS (0.55%) and SBIO (0.44%). \n 1 income and other fund on it is listed below.\n Thematic and core funds that hold it\n Fund Name Share of the fund Holdings filed Asset \n XPH State Street SPDR S&P Pharmaceuticals ETF 0.85% Nov 3, 2026 Equity \n DWAS Invesco Dorsey Wright SmallCap Momentum ETF 0.55% Nov 3, 2026 Equity \n SBIO ALPS Medical Breakthroughs ETF 0.44% Aug 31, 2026 Equity \n QQQS Invesco NASDAQ Future Gen 200 ETF 0.35% Nov 3, 2026 Equity \n FSEG Fidelity Enhanced Small Cap Growth ETF 0.14% Jun 30, 2026 Equity \n IWC iShares Micro-Cap ETF 0.11% Nov 3, 2026 Equity \n VFMO Vanguard U.S. Momentum Factor ETF 0.09% Sep 30, 2026 Equity \n FSEV Fidelity Enhanced Small Cap Value ETF 0.08% Jun 30, 2026 Equity \n IBBQ Invesco Nasdaq Biotechnology ETF 0.04% Nov 3, 2026 Equity \n VTWG Vanguard Russell 2000 Growth ETF 0.04% Sep 30, 2026 Equity \n IBB iShares Biotechnology ETF 0.03% Nov 3, 2026 Equity \n IWO iShares Russell 2000 Growth ETF 0.03% Nov 3, 2026 Equity \n RESM Columbia Research Enhanced Small Cap ETF 0.03% Jun 30, 2026 Equity \n GSSC GS ActiveBeta U.S. Small Cap Equity ETF 0.03% Aug 31, 2026 Equity \n FESM Fidelity Enhanced Small Cap Core ETF 0.02% Jun 30, 2026 Equity \n PRFZ Invesco RAFI US 1500 Small-Mid ETF 0.02% Nov 3, 2026 Equity \n VTWO Vanguard Russell 2000 ETF 0.02% Sep 30, 2026 Equity \n RSSL Global X Russell 2000 ETF 0.02% Jul 31, 2026 Equity \n OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.01% Nov 3, 2026 Equity \n IWM iShares Russell 2000 ETF 0.01% Nov 3, 2026 Equity \n VXF Vanguard Extended Market ETF 0.01% Sep 30, 2026 Equity \n VHT Vanguard Health Care ETF 0.01% Sep 30, 2026 Equity \n VTWV Vanguard Russell 2000 Value ETF 0.01% Sep 30, 2026 Equity \n IWN iShares Russell 2000 Value ETF Nov 3, 2026 Equity \n DFAS U.S. Small Cap Portfolio: ETF Class Shares Jul 31, 2026 Equity \n DFAU Dimensional US Core Equity Market ETF Jul 31, 2026 Equity \n VTHR Vanguard Russell 3000 ETF Sep 30, 2026 Equity \n VTI Vanguard Morningstar Total Stock Market ETF Sep 30, 2026 Equity \n Income and other funds that hold it\n Fund Name Share of the fund Holdings filed Category \n ITWO ProShares Russell 2000 High Income ETF 0.02% Aug 31, 2026 Income \n What this counts\n Aclaris Therapeutics (ticker ACRS, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund\u2019s N-PORT asset type. A fund holding only the company\u2019s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.\n Each row shows the date the fund last filed.\n Look up another company .\n Questions people ask\n Which ETFs hold Aclaris Therapeutics? 28 thematic and core ETFs hold Aclaris Therapeutics, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are XPH at 0.85% of the fund on Nov 3, 2026, DWAS at 0.55% of the fund on Nov 3, 2026 and SBIO at 0.44% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart. \n Cite this page. ETFIQ, ETFs holding ACLARIS THERAPEUTICS, data as of Nov 5, 2026. https://etfiq.com/holdings/acrs/ Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data .\n Other forms Plain ETFIQ, ETFs holding ACLARIS THERAPEUTICS, data as of Nov 5, 2026. https://etfiq.com/holdings/acrs/ APA ETFIQ. (Nov 5, 2026). ETFs holding ACLARIS THERAPEUTICS. Retrieved from https://etfiq.com/holdings/acrs/ Markdown [ETFs holding ACLARIS THERAPEUTICS (ETFIQ, Nov 5, 2026)](https://etfiq.com/holdings/acrs/)","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, ETFs holding ACLARIS THERAPEUTICS, data as of Nov 5, 2026. https://etfiq.com/holdings/acrs/"}